Advertisement

Reactions Weekly

, Volume 1731, Issue 1, pp 100–100 | Cite as

Docetaxel/pertuzumab/trastuzumab

Diarrhoea, acute renal failure and cardiac toxicities: 2 case reports
Case report
  • 3 Downloads

Reference

  1. Stefanou D, et al. Subcutaneous trastuzumab combined with pertuzumab and docetaxel as first-line treatment of advanced HER2-positive breast cancer. Anticancer Research 38: 6565-6569, No. 11, Nov 2018. Available from: URL: http://doi.org/10.21873/anticanres.13023 - GreeceCrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations